KALI IODATUM

Manufacturer
Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | Rxhomeo, Inc
Effective date
2015-12-30
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:07:13

Label at a glance#

ProductKALI IODATUM
Active ingredientPOTASSIUM IODIDE
Label structure9 sections

Indications and uses

Head Cold, Catarrh

Storage and handling

Store in a cool dark place

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

KALI IODATUM HPUS 1X and Higher

USES

OTC - PURPOSE SECTION

Head Cold, Catarrh

INDICATIONS

INDICATIONS & USAGE SECTION

Condition listed above or as directed by the physician

DOSAGE

DOSAGE & ADMINISTRATION SECTION

Adults- Take 4 or 6 Tablets by mouth, three times daily or as suggested by physician. Children 2 years and older- take 1/2 the adult dose.

WARNINGS

WARNINGS SECTION

This product is to be used for self-limiting conditions

OTC - STOP USE SECTION

If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional

OTC - PREGNANCY OR BREAST FEEDING SECTION

As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medication out of reach of children

OTC - DO NOT USE SECTION

Do not use if capseal is broken or missing.

Close the cap tightly after use.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Lactose

STORAGE

STORAGE AND HANDLING SECTION

Store in a cool dark place

QUESTIONS OR COMMENTS

OTC - QUESTIONS SECTION

www.Rxhomeo.com | 1.888.2796642 | info@rxhomeo.com

Rxhomeo, Inc 9415 Burnet Road, Suite 312, Austin, TX 78758

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-138907460005526GTIN-13: 8907460005526
EAN-13: 8907460005526
GTIN storage (14 digits): 08907460005526
15631-0610.jpg
QR code linkQR Codewww.rxhomeo.com/15631-0610.jpg

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
15631-0610-0KALI IODATUM1 in 1 BLISTER PACKTABLET12
15631-0610-1KALI IODATUM4 in 1 BLISTER PACKTABLET42
15631-0610-2KALI IODATUM50 in 1 CONTAINERTABLET502
15631-0610-3KALI IODATUM100 in 1 CONTAINERTABLET1002
15631-0610-4KALI IODATUM250 in 1 CONTAINERTABLET2502
15631-0610-5KALI IODATUM500 in 1 CONTAINERTABLET5002
15631-0610-6KALI IODATUM1000 in 1 CONTAINERTABLET10002
15631-0610-7KALI IODATUM10000 in 1 CONTAINERTABLET100002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
15631-0610KALI IODATUM TABLET [RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC]2Legacy NDC, 8 package rows20151230_ac80beeb-cc53-4dc6-ab14-e6c12f22e474.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
POTASSIUM IODIDE1C4QK22F9JACTIM
LACTOSEJ2B2A4N98GIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4dd98180-d251-422c-8b27-1b257e19e703ac80beeb-cc53-4dc6-ab14-e6c12f22e4742015-12-30WarningsExact identifier
spl id: 4dd98180-d251-422c-8b27-1b257e19e703
spl set id: ac80beeb-cc53-4dc6-ab14-e6c12f22e474

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.